Advertisement

Topics

Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease

10:04 EST 20 Dec 2017 | Labiotech.eu

BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets for chronic liver disease.  BiomX is a company based in Ness Ziona, Israel, developing customized phage therapy to selectively destroy the bacteria that cause diseases ...

This awesome article Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease

NEXT ARTICLE

More From BioPortfolio on "Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...